Inflammatory bowel disease: 1. Origins, presentation, and course

Postgraduate Medicine

Volumn 103, Issue 5, 1998, Pages 77-102

  Moses, Peter L ^a   Moore, Brad R ^a   Ferrentino, Nicholas ^a   Bensen, Steven P ^a   Vecchio, James A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; IMMUNOPATHOGENESIS; REVIEW; RISK FACTOR; ULCERATIVE COLITIS;

EID: 0031800254     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.05.483     Document Type: Review

References (32)

1. Mendeloff AI. Newer concepts of IBD epidemiology. In: Rachmilewitz D, ed. Inflammatory bowel diseases: proceedings of the International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 7-9, 1981. Boston: Kluwer, 1982:137-42
2. Gilat T, Grossman A, Fireman Z, et al. Inflammatory bowel disease in Jews. In: McConnell RB, Rozen R, Langman M, et al, eds. The genetics and epidemiology of inflammatory bowel disease. Vol 11. New York: Karger, 1986:135-40
3. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29(10):913-20
4. Yang H, Shohat T, Rotter JI. The genetics of inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier, 1992:17
5. Farmer RG, Michener WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980;9(2):271-7
6. Neigut D, Proujansky R, Trucco M, et al. Association of an HLA-DQB-1 genotype with Crohn's disease in children. (Abstr) Gastroenterology 1992;102(4 Pt 2): A671
7. Toyoda H, Wang SJ, Yang HY, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104(3):741-8
8. Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100(6):1590-6
9. MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 1994;78(6):1207-31
10. Teahon K, Smethurst P, Levi AJ, et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33(3):320-3
11. Wolf JL, Rubin DH, Finberg R, et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science 1981; 212(4493):471-2
12. Hanson LA, Ahlstedt S, Andersson B, et al. The biologic properties of secretory IgA. J Reticuloendothel Soc 1980; 28(Suppl):1-9S
13. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153-245
14. Underdown BJ, Schiff JM. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu Rev Immunol 1986;4:389-417
15. Nielsen OH, Elmgreen J, Ahnfelt-Ronne I. Serum interferon activity in inflammatory bowel disease: arachidonic acid release and lipoxygenation activated by alpha-class interferon in human neutrophils. Inflammation 1988;12(2):169-79
16. Brandtzaeg P, Sollid LM, Thrane PS, et al. Lymphoepithelial interactions in the mucosal immune system. Gut 1988;29(8): 1116-30
17. Tomasi TB Jr, Tan EM, Soloman A, et al. Characteristics of an immune system common to certain external secretions. J Exp Med 1965;121(1):101-24
18. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974; 66(2):189-203
19. Schreiber S, Raedler A, Stenson WF, et al. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992;21(2):451-502
20. Kirschner BS. Does acute infection trigger chronic inflammation in pediatric patients with chronic inflammatory bowel disease? Gastroenterology 1993;104(4 Pt 2): A725
21. Schumacher G, Kollberg B, Sandstedt B, et al. A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis: microbiologic findings. Scand J Gastroenterol 1993;28(12): 1077-85
22. Kühn R, Löhler J, Rennick D, et al. Intetleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75(2): 263-74
23. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75(2):253-61
24. Farmer RG, Hawk WA, Turnbull RB Jr. Regional enteritis of the colon: a clinical and pathologic comparison with ulcerative colitis. Am J Dig Dis 1968;13(6): 501-14
25. Watts JM, De Dombal FT, Watkinson G, et al. Early course of ulcerative colitis. Gut 1966;7(1):16-31
26. Both H, Torp-Pedersen K, Kreiner S, et al. Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group. Scand J Gastroenterol 1983;18(7):987-91
27. Ogorek CP, Fisher RS. Differentiation between Crohn's disease and ulcerative colitis. Med Clin North Am 1994; 78(6):1249-58
28. Jewel DP. Ulcerative colitis in gastrointestinal disease. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 5th ed. Philadelphia: Saunders, 1993: 1305-30
29. 28 p 1270-1304
30. Hanauer SB, Shulman MI. Inflammatory bowel disease: new therapeutic approaches. Gastroenterol Clin North Am 1995;24(3):523-40
31. Kirsner JB. Problems in the differentiation of ulcerative colitis and Crohn's disease of the colon: the need for repeated diagnostic evaluation. (Editorial) Gastroenterology 1975;68(1):187-91
32. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report of a therapeutic trial. Br Med J 1955;2:1041